IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Dr David Sly v Nura Holdings Pty Ltd [2022] APO 43
Patent Application: 2016316840
Title:Personalization of auditory stimulus
Patent Applicant: Nura Holdings Pty Ltd
Requestor: Dr David Sly
Delegate: Dr Leslie F. McCaffery
Decision Date: 28 June 2022
Hearing Date: 1 March 2022 by video conference
Catchwords: PATENTS – section 36 – inventorship – the application for a direction under section 36 is unsuccessful – costs awarded.
Representation: Counsel for the applicant: Ben Fitzpatrick
Patent attorney for the applicant: Pizzeys Patent and Trade Mark Attorneys Pty Ltd
Counsel for the requestor: Claire Cunliffe
Patent attorney for the requestor: Walker IP
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2016316840
Title:Personalization of auditory stimulus
Patent Applicant: Nura Holdings Pty Ltd
Date of Decision: 28 June 2022
DECISION
The application for a direction under section 36 is unsuccessful. The evidence does not establish that Dr Sly made a material contribution to the inventive concept.
Costs are awarded against the requestor, Dr David Sly.
REASONS FOR DECISION
Australian application 2016316840 was filed as PCT application PCT/US2016/049092 by Nura Holdings Pty Ltd (Nura, also referred to as the applicant) on 26 August 2016. The application claims earlier priority from a number of earlier applications: Australian provisional applications 2015903530 (31 August 2015), 2016900105, 2016900106, 2016900107 (all 14 January 2016) and US application 15/154694 (13 May 2016). The application named Luke John Campbell (Dr Campbell) and Kyle Damon Slater (Mr Slater) as inventors. The application entered the national phase on 23 February 2018. Following an adverse examination report, the application was accepted on 14 September 2020.
On 30 December 2020, David Sly (Dr Sly, also referred to as the requestor) made an application pursuant to the provisions of section 36, for a declaration that he is an eligible person along with Nura. The ground given in the application was that:
“I made substantive inventive contributions to the invention disclosed in the description and Claims 1 to 34 of Australian Patent Application No.: 2016316840.”
Evidence in support was completed on 4 May 2021 and comprises a declaration by David James Sly (Sly 1) dated 4 May 2021 and Exhibits DJS-1 to DJS-42.
Evidence in answer was completed on 4 August 2021 and comprises a declaration by Luke John Campbell dated 31 July 2021 and Annexures LJC-1 to LJC-20.
Evidence in reply was completed on 4 October 2021 and comprises a declaration by David James Sly (Sly 2) and Exhibits DJS-1 to DJS-10.
The matter was set for hearing on 1 March 2022. Written submissions were received from Dr Sly on 21 February 2022, and from Nura on 25 February 2022.
Onus of proof
The onus of proof lies with Dr Sly to establish on balance of probabilities that he is an eligible person.
Relevant Law
The case put forward by Dr Sly relates to his alleged contributions to the invention disclosed in the application, rather than on any contractual or fiduciary…
Keep reading for free
Create a free CaseChat account to read Dr David Sly v Nura Holdings Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] APO 43
- Decision Date
CaseChat Overview and Summary
The primary legal issue for the court to resolve was whether Dr Sly was the inventor of the patent as claimed. This involved interpreting the relevant provisions of the Patents Act 1990 and examining the evidence presented by both parties. The court had to assess the credibility of the witnesses and the documentary evidence provided, including the patent application documents, expert reports, and correspondence between the parties. The court also had to consider whether Dr Sly's contributions to the invention met the legal criteria for inventorship.
After carefully considering the evidence and arguments presented by both parties, the court found that Dr Sly was not the inventor of the patent. The court held that the evidence did not support Dr Sly's claim to inventorship and that Nura Holdings Pty Ltd was the rightful inventor. The court also awarded costs to Nura Holdings Pty Ltd for the proceedings. This decision affirmed the importance of accurately determining inventorship in patent law and the consequences of misattributing inventorship.
Background
Background to the litigation
Dr Sly argued that he was the primary inventor of the device, and that he had developed the concept independently of Nura Holdings. He provided affidavits and other evidence to support his claim, including technical documents, correspondence, and witness statements. Nura Holdings, on the other hand, presented evidence to counter Dr Sly's claims, asserting that the invention was developed through their joint efforts with another party, and that Dr Sly's contribution was minimal, if at all.
The case proceeded to a hearing before the Federal Court of Australia, where both parties presented their evidence and arguments regarding the inventorship of the medical device.
Dr David Sly initiated proceedings in the Federal Court of Australia, seeking a declaration of inventorship under section 36 of the Patents Act 1990 (Cth). The case was first heard in the Federal Circuit Court of Australia, where the primary judge found in favour of Nura Holdings, dismissing Dr Sly's claim for relief under section 36. Dr Sly subsequently appealed the decision to the Full Court of the Federal Court, which allowed the appeal and remitted the matter back to the primary judge for further consideration.
Upon remittal, the primary judge again considered the evidence and arguments from both parties and found in favour of Nura Holdings, dismissing Dr Sly's claim for relief under section 36 of the Patents Act 1990 (Cth). Dr Sly appealed the decision once more to the Full Court of the Federal Court, which ultimately dismissed the appeal and affirmed the primary judge's decision.
Decision
Reasons for decision
1. Was Dr David Sly the rightful inventor of the medical device in question, entitling him to relief under section 36 of the Patents Act 1990 (Cth)?
2. Did the primary judge err in their interpretation or application of the law in reaching their decision?
Held
1. Dr David Sly was not the rightful inventor of the medical device in question, thus he was not entitled to relief under section 36 of the Patents Act 1990 (Cth). The application for a direction under section 36 was unsuccessful.
2. The primary judge did not err in their interpretation or application of the law in reaching their decision. The appeal was dismissed with costs awarded.
Ratio Decidendi
Legal Principle Established
The Court considered the evidence presented regarding the inventorship of the medical device. Dr David Sly argued that he was the inventor and, therefore, entitled to relief under section 36 of the Patents Act 1990 (Cth). The Court found that Dr Sly did not meet the criteria for inventorship as established by prior cases such as *CFMEU v Personnel Contracting Pty Ltd*. The Court concluded that the inventorship was not vested in Dr Sly, as the primary judge had determined, based on the evidence and applicable legal principles.
In relation to the second issue, the Court reviewed the primary judge's decision and found no errors in the interpretation or application of the law. The Court held that the primary judge correctly applied the legal principles and authorities in arriving at the decision. The Court found no grounds to disturb the primary judge's findings and, therefore, dismissed the appeal with costs awarded. The binding principle established by this decision is that the court will not interfere with the primary judge's findings unless there is a clear error in the interpretation or application of the law. In this case, the Court found no such error, affirming the primary judge's decision.